tirzepatide surmount Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study Tirzepatide vs. Semaglutide for Weight

2 way Dual Activation GHRH-R (CJC-1295) + GHS-R1a (Ipamorelin) two complementary pituitary targets 2-4x GH AUC Demonstrated Synergy Area under the GH curve 2 to 4 times greater than each peptide in monotherapy 5.8 - 8.1 days CJC-1295 Half-Life Sustained elevation of IGF-1 for 9 to 11 days after a single injection 10 mg Pre-formulated mix 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin per vial | Purity 99% HPLC Selective Hormonal Profile Ipamorelin: no increase in cortisol, prolactin or ACTH (Raun et al., 1998) Mechanism of Action Dual-Channel Synergy Simultaneous activation of GHRH-R and GHS-R1a for amplified GH stimulation GHRH Lane CJC-1295 GHRH Analog (Mod GRF 1-29) A synthetic peptide of 29 amino acids that selectively binds to the GHRH receptor on pituitary somatotroph cells

Carnitine is an essential metabolite for fatty acid oxidation, as it facilitates the transport of long-chain fatty acids into mitochondria through the carnitine shuttle system, which involves carnitine palmitoyltransferase 1 (CPT1), carnitine-acylcarnitine translocase (CACT), and CPT2

Whether your feet are worn down due to aging or to recent weight loss, we're here to help

This is in stark contrast to those who received the placebo

This suggests that increased ICP may be associated with increased AQP1 levels in the CP